abstract |
The present invention relates to the encapsulation of niflumic acid and its derivatives in synthetic esters in liposomes in order to provide a new transdermal, non-steroidal anti-inflammatory composition. Niflumic acid and its esters are encapsulated in liposomes made of various lipids to provide a drug with increased efficacy. The liposome suspension itself is prepared in a form of an ointment and filled with a stable substance and is subjected to stability testing with the final formulation. HE |